The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer

Myeloperoxidase and free iron levels: Potential biomarkers for early detection and prognosis of ovarian cancer

(2017) Nicole M. Fletcher et al.   Cancer Biomarkers

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

(2012) Ahmed Y. Ali et al.   Annals of the New York Academy of Sciences

Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation

(2012) E. V. Kalinina et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Molecular Mechanisms of Hypertension—Reactive Oxygen Species and Antioxidants: A Basic Science Update for the Clinician

(2012) Augusto C. Montezano et al.   CANADIAN JOURNAL OF CARDIOLOGY

Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival

(2012) Joyce Liu et al.   Cancer Genetics

Modulation of redox signaling promotes apoptosis in epithelial ovarian cancer cells

(2011) Zhongliang Jiang et al.   GYNECOLOGIC ONCOLOGY

Nitric Oxide and Cyclic GMP as Pro-and Anti-Apoptotic Agents

(2010) Ronald R. Fiscus et al.   JOURNAL OF CARDIAC SURGERY

Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer

(2009) Ghassan M. Saed et al.   GYNECOLOGIC ONCOLOGY

The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?

(2008) Miguel Lopez-Lazaro   Anti-Cancer Agents in Medicinal Chemistry

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance

(2008) E L Leung et al.   BRITISH JOURNAL OF CANCER

Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin

(2008) Verena Fetz et al.   INTERNATIONAL JOURNAL OF CANCER